{"version":"1.0","type":"link","title":"Impact of durable response of first-line systemic treatment for patients with locally advanced or metastatic urothelial carcinoma: data update of EV-302/KEYNOTE-A39 trial.","author_name":"Miyake M 외","author_url":"https://prs-insight.online/author/Miyake%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/169413","thumbnail_width":1200,"thumbnail_height":630}